FDA guidance
Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Guidance for…
FDA guidance · Final · issued Sep 30, 2016
Key facts
| Title | Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Guidance for Industry |
|---|---|
| Status | Final |
| Issue date | Sep 30, 2016 |
| Center | Center for Drug Evaluation and Research |
| Issuing office | Center for Biologics Evaluation and Research, Center for Drug Evaluation and Research |
| Communication type | Guidance Document |
| Regulated product | Drugs |
| Docket number | FDA-1995-D-0288 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents